1985
DOI: 10.1142/s0192415x85000113
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Ba-wei-wan (Hachimijiogan) on Plasma Levels of High Density Lipoprotien-cholesterol and Lipoperoxide in Aged Individuals

Abstract: Ba-wei-wan was administered for 7 months to 24 aged, non-hospitalized subjects. Laboratory examinations showed an improvement in serum or plasma levels of total lipid, LPO and HDL-C. Other blood examinations were shown to be unaffected by the treatment. To reconfirm the effects of Ba-wei-wan on lipid metabolism, the three step administration of the drug was employed. The elevation of HDL-C levels and the decrease of LPO levels were obtained by this treatment. The discontinuation of this drug induced the conver… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Our study of transfection into CV1 cells clearly showed that Hachimi-jio-gan activated DR1 luciferase activity and this activation is PPARα-specific. Hachimi-jio-gan was reported to have favorable effects on lipid [11] and glucose metabolism [5,13]; however, this mechanism has not been resolved. Our study suggested one possibility that the effect of Hachimi-jio-gan was induced by PPARα activation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our study of transfection into CV1 cells clearly showed that Hachimi-jio-gan activated DR1 luciferase activity and this activation is PPARα-specific. Hachimi-jio-gan was reported to have favorable effects on lipid [11] and glucose metabolism [5,13]; however, this mechanism has not been resolved. Our study suggested one possibility that the effect of Hachimi-jio-gan was induced by PPARα activation.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Hachimijio-gan was reported to suppress hyperglycemia via insulin production and secretion from the pancreas [5]. In addition, Hachimi-jio-gan has been widely used for the treatment of many chronic diseases such as renal nephritis [6], vegetative ataxia [7], major depressive disorder [8,9], hyperprolactinemia [10], and hyperlipidemia [11]; however, the mechanisms of Hachimijio-gan remain unclear. The objective of this study was to investigate whether Hachimi-jio-gan has functions related to hormonal effects using transfection assays with thyroid hormone receptor, androgen receptor, estrogen receptor, estrogen receptor, RXR, PPARγ, and PPARα into several cell lines.…”
mentioning
confidence: 99%